Achieve Life Sciences, Inc.

Healthcare · Biotechnology · United States

Last price 6.83 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 702.82M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.